259 related articles for article (PubMed ID: 34393627)
1. Age-Related Macular Degeneration: What Do We Know So Far?
Ma HH; Liutkevičienė R
Acta Med Litu; 2021; 28(1):36-47. PubMed ID: 34393627
[TBL] [Abstract][Full Text] [Related]
2. Age-related macular degeneration and myeloproliferative neoplasms - A common pathway.
Liisborg C
Acta Ophthalmol; 2022 Oct; 100 Suppl 271(Suppl 271):3-35. PubMed ID: 36200281
[TBL] [Abstract][Full Text] [Related]
3. A Linkage between Angiogenesis and Inflammation in Neovascular Age-Related Macular Degeneration.
Heloterä H; Kaarniranta K
Cells; 2022 Nov; 11(21):. PubMed ID: 36359849
[TBL] [Abstract][Full Text] [Related]
4. Age-related macular degeneration--emerging pathogenetic and therapeutic concepts.
Gehrs KM; Anderson DH; Johnson LV; Hageman GS
Ann Med; 2006; 38(7):450-71. PubMed ID: 17101537
[TBL] [Abstract][Full Text] [Related]
5. Age-Related Macular Degeneration: An Exponentially Emerging Imminent Threat of Visual Impairment and Irreversible Blindness.
Chaudhuri M; Hassan Y; Bakka Vemana PPS; Bellary Pattanashetty MS; Abdin ZU; Siddiqui HF
Cureus; 2023 May; 15(5):e39624. PubMed ID: 37388610
[TBL] [Abstract][Full Text] [Related]
6. Tissue engineering in age-related macular degeneration: a mini-review.
Wu A; Lu R; Lee E
J Biol Eng; 2022 May; 16(1):11. PubMed ID: 35578246
[TBL] [Abstract][Full Text] [Related]
7. Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.
Chew EY; Clemons TE; Agrón E; Sperduto RD; Sangiovanni JP; Davis MD; Ferris FL;
JAMA Ophthalmol; 2014 Mar; 132(3):272-7. PubMed ID: 24385141
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Evans JR; Lawrenson JG
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD000254. PubMed ID: 28756618
[TBL] [Abstract][Full Text] [Related]
9. CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD.
Magnusson KP; Duan S; Sigurdsson H; Petursson H; Yang Z; Zhao Y; Bernstein PS; Ge J; Jonasson F; Stefansson E; Helgadottir G; Zabriskie NA; Jonsson T; Björnsson A; Thorlacius T; Jonsson PV; Thorleifsson G; Kong A; Stefansson H; Zhang K; Stefansson K; Gulcher JR
PLoS Med; 2006 Jan; 3(1):e5. PubMed ID: 16300415
[TBL] [Abstract][Full Text] [Related]
10. Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging.
Bowes Rickman C; Farsiu S; Toth CA; Klingeborn M
Invest Ophthalmol Vis Sci; 2013 Dec; 54(14):ORSF68-80. PubMed ID: 24335072
[TBL] [Abstract][Full Text] [Related]
11. Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy.
Deng Y; Qiao L; Du M; Qu C; Wan L; Li J; Huang L
Genes Dis; 2022 Jan; 9(1):62-79. PubMed ID: 35005108
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress, innate immunity, and age-related macular degeneration.
Shaw PX; Stiles T; Douglas C; Ho D; Fan W; Du H; Xiao X
AIMS Mol Sci; 2016; 3(2):196-221. PubMed ID: 27239555
[TBL] [Abstract][Full Text] [Related]
13. Developing and validating a multivariable prediction model which predicts progression of intermediate to late age-related macular degeneration-the PINNACLE trial protocol.
Sutton J; Menten MJ; Riedl S; Bogunović H; Leingang O; Anders P; Hagag AM; Waldstein S; Wilson A; Cree AJ; Traber G; Fritsche LG; Scholl H; Rueckert D; Schmidt-Erfurth U; Sivaprasad S; Prevost T; Lotery A
Eye (Lond); 2023 Apr; 37(6):1275-1283. PubMed ID: 35614343
[TBL] [Abstract][Full Text] [Related]
14. Cataract Surgery and the Risk of Developing Late Age-Related Macular Degeneration: The Age-Related Eye Disease Study 2 Report Number 27.
Bhandari S; Vitale S; Agrón E; Clemons TE; Chew EY;
Ophthalmology; 2022 Apr; 129(4):414-420. PubMed ID: 34793832
[TBL] [Abstract][Full Text] [Related]
15. Altered photoreceptor metabolism in mouse causes late stage age-related macular degeneration-like pathologies.
Cheng SY; Cipi J; Ma S; Hafler BP; Kanadia RN; Brush RS; Agbaga MP; Punzo C
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13094-13104. PubMed ID: 32434914
[TBL] [Abstract][Full Text] [Related]
16. [Age-related Macular Degeneration in the Japanese].
Yoshimura N
Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):163-88; discussion 189. PubMed ID: 27164756
[TBL] [Abstract][Full Text] [Related]
17. Association between Patient-Reported Outcomes and Time to Late Age-Related Macular Degeneration in the Laser Intervention in Early Stages of Age-Related Macular Degeneration Study.
McGuinness MB; Finger RP; Wu Z; Luu CD; Chen FK; Arnold JJ; Chakravarthy U; Guymer RH;
Ophthalmol Retina; 2020 Sep; 4(9):881-888. PubMed ID: 32418845
[TBL] [Abstract][Full Text] [Related]
18. Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions.
Cabral de Guimaraes TA; Daich Varela M; Georgiou M; Michaelides M
Br J Ophthalmol; 2022 Mar; 106(3):297-304. PubMed ID: 33741584
[TBL] [Abstract][Full Text] [Related]
19. Laser treatment of drusen to prevent progression to advanced age-related macular degeneration.
Virgili G; Michelessi M; Parodi MB; Bacherini D; Evans JR
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD006537. PubMed ID: 26493180
[TBL] [Abstract][Full Text] [Related]
20. Reticular Pseudodrusen: The Third Macular Risk Feature for Progression to Late Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report 30.
Agrón E; Domalpally A; Cukras CA; Clemons TE; Chen Q; Lu Z; Chew EY; Keenan TDL;
Ophthalmology; 2022 Oct; 129(10):1107-1119. PubMed ID: 35660417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
